Abstract:Abstract Background We used a transparent machine learning algorithm to identify subtypes of white matter damage in aging and to characterize their clinical representations. White matter hyperintensities (WMH), a common finding on brain magnetic resonance imaging (MRI), are known to be associated with cognitive impairment and dementia. Previous studies have shown spatial heterogeneity of WMH appearance, but the contribution of Alzheimer disease (AD) dementia and related genetic risk factors to this heterogeneity remains unclear. We sought to investigate the heterogeneity of WMH, in the general population, leveraging state of the art pattern analysis methods and exploring whether the APOE genotype is contributing to this heterogeneity. Method A sample of N=1836 people was obtained from the Study of Health in Pomerania (SHIP), Germany, covering a wide age range (22–84 years, median age 52.2±13.16). WMH were automatically segmented on multi‐modal MRI scans and decomposed into four spatially distinctive components using Non‐Negative Matrix Factorization (NNMF), a machine‐learning based structural covariance method. Associations of these components with the APOE genotype (available for n=303) was investigated in subjects older than 60 years of age, using a multivariable linear regression model for each component, with WMH component loadings as the outcome variable and APOE genotype (encoded as shown in Table 1) as the independent variable. Age, sex and ship sub‐cohort were included as covariates. All reported P‐values were Bonferroni corrected for multiple comparisons. Result Data‐driven approach identified four WMH components, consistent with clinical categorization in deep and periventricular lesions, while further dividing periventricular WMH into posterior, frontal and dorsal components (Figure 1). APOE genotype was significantly associated with the dorsal periventricular WMH component (P=0.035, Bonferroni corrected), but not with the other three WMH components (Table 1). Conclusion We obtained a high consistency of data‐driven WMH components and established clinical categorizations. Our data demonstrated that the appearance of WMH follows heterogeneous regional distribution patterns. Additionally, the APOE genotype, the strongest genetic risk factor for sporadic AD, is specifically associated with one of the components indicating spatial specificity and a potential link to early MRI changes in the predementia phase.

Relationship between brain white matter damage and grey matter atrophy in hereditary spastic paraplegia types 4 and 5

Mutation and Clinical Characteristics of Autosomal-Dominant Hereditary Spastic Paraplegias in China

Novel Mutations in the SPAST Gene Cause Hereditary Spastic Paraplegia.

Molecular genetics study of hereditary spastic paraplegia accompanied by distal amyotrophy-an update

Brain Damage and Gene Expression Across Hereditary Spastic Paraplegia Subtypes

Genetic Analysis of SPG4 and SPG3A Genes in a Cohort of Chinese Patients with Hereditary Spastic Paraplegia.

A Novel Candidate Locus on Chromosome 11P14.1-P11.2 for Autosomal Dominant Hereditary Spastic Paraplegia

Exon 8-17 Deletions of Spast in A Chinese Family with Hereditary Spastic Paraplegia: A Case Report and Literature Review

Characteristics of Clinical and Spastin Gene Mutation in a Family with Hereditary Spastic Paraplegia

Clinical Features of Hereditary Spastic Paraplegia with Thin Corpus Callosum: Report of 5 Chinese Cases.

Receptor Expression-Enhancing Protein 1 Gene (SPG31) Mutations Are Rare in Chinese Han Patients with Hereditary Spastic Paraplegia.

Gray matter atrophy in progressive supranuclear palsy: meta-analysis of voxel-based morphometry studies

White Matter Alterations in Spastic Paraplegia Type 5: A Multiparametric Structural MRI Study and Correlations with Biochemical Measurements

Genetic, clinical and neuroimaging profiles of sporadic and autosomal recessive hereditary spastic paraplegia cases in Chinese

Progress of pathogenesis of hereditary spastic paraplegia type 4

Clinical and Genetic Spectrum in a Large Cohort of Hereditary Spastic Paraplegia

Metabolite profile in hereditary spastic paraplegia analyzed using magnetic resonance spectroscopy: a cross-sectional analysis in a longitudinal study

Clinical features and genetic spectrum of Chinese patients with hereditary spastic paraplegia: A 14-year study

Data‐driven approach reveals heterogeneity and region‐specific association of white matter hyperintensities with the APOE genotype

Retinal ganglion cell and microvascular density loss in hereditary spastic paraplegia

Alu -specific microhomology-mediated deletion of the final exon of SPAST in three unrelated subjects with hereditary spastic paraplegia